The members listed below represent scientists and physicians across the Vanderbilt community who are leaders in areas relevant to the mission of the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4).
Director
Executive Positions
-
-
James E. Cassat, MD, PhD
Associate Director, (VI4)Institute for Infection, Immunology and Inflammation -
Ivelin Georgiev, PhD
Director - Vanderbilt Program in Computational Microbiology and Immunology -
Maria Hadjifrangiskou, PhD
Associate Director, Vanderbilt Institute for Infection, Immunology and Inflammation -
Mary Philip, MD, PhD
Associate Director, (VI4) Institute for Infection, Immunology and Inflammation -
The Strategic Planning Committee
-
-
-
-
Anthony R. Flores, MD, MPH, PhD, FPIDS
Director, Pediatric Infectious Diseases -
-
-
-
Simon A. Mallal, MBBS, FRACP, FRCPA
Director, Vanderbilt Center for Translational and Clinical Immunology -
-
-
-
External Advisory Board
-
William Goldman, Ph.D.
ProfessorUniversity of North Carolina at Chapel Hill -
Lora Hooper, Ph.D.
ProfessorDepartment of Immunology at the University of Texas Southwestern Medical Center -
Scott Hultgren, Ph.D.
Professor of Molecular MicrobiologyDirector of the Center for Women’s Infectious Disease Research at Washington University in St. Louis -
Susan Kaech, Ph.D.
Professor, Salk InstituteDirector of the NOMIS Center for Immunobiology and Microbial Pathogenesis -
Richard Locksley, M.D.
Professor of MedicineDirector of the Sandler Asthma Basic Research (SABRE) Center at the University of California, San Francisco
Staff
-
Jamie Block
Program ManagerVanderbilt Institute for Infection, Immunology & Inflammation (VI4) -
Fredrick Haywood, Jr., MBA
Communications Project ManagerVanderbilt Institute for Infection, Immunology & Inflammation (VI4) | Pathology, Microbiology and Immunology -
-
Megan Schladt, M.S.
Lead Program ManagerVanderbilt Institute for Infection, Immunology & Inflammation (VI4)